Healthcare Industry News: Bovie
News Release - March 30, 2010
Bovie Medical Corporation Announces 510(K) Application for a New Office Based High Frequency Electrosurgical GeneratorMELVILLE, N.Y.--(HSMN NewsFeed)--Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company has applied for 510(k) clearance from the Food and Drug Administration (FDA) to market a new high frequency electrosurgical generator specifically designed for the physician office market. The Company already manufactures a full line of electrosurgical generators for the physician office and markets them through their distribution partners worldwide. This new high frequency electrosurgical generator known as the 1450RF expands the line of Bovie’s current offerings.
For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie’s website www.Boviemedical.com.
Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.
Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission. For forward-looking statements in this new release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.
Source: Bovie Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.